Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

4Total
Not Applicable (4)

Trial Status

Recruiting3
Not Yet Recruiting2

Clinical Trials (5)

Showing 5 of 5 trials
NCT05834803Not ApplicableRecruiting

Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.

NCT07111442Not ApplicableNot Yet RecruitingPrimary

A Placebo-controlled Trial of Fractional Flow Reserve-guided Percutaneous Renal Artery Stenting Among Atherosclerosis Renal-vascular Hypertension Patients

NCT06913530Not Yet Recruiting

European Multicentre Study of Long-term Results Following Visceral Arteries Revascularization: the E-VisAR Study

NCT06447740Not ApplicableRecruitingPrimary

Fractional Flow Reserve-guided Stenting Versus Medical Therapy in Atherosclerosis Renal Artery Stenosis

NCT05732077Not ApplicableRecruitingPrimary

Fractional Flow Reserve to Determine Atherosclerosis Renovascular Hypertension Stenting

Showing all 5 trials

Research Network

Activity Timeline